Barbui C, Conti V, Purgato M, Cipriani A, Fortino I, Rivolta AL, et al. Use of antipsychotic drugs and mood stabilizers in women of childbearing age with schizophrenia and bipolar disorder: Epidemiological survey. Epidemiol Psychiatric Sci. 2013;22:355–61.
Buchanan RW, Kreyenbuhl J, Kelly DL, Noel JM, Boggs DL, Fischer BA, et al. The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophr Bull. 2010;36:71–93.
Jones I, Chandra PS, Dazzan P, Howard LM. Bipolar disorder, affective psychosis, and schizophrenia in pregnancy and the post-partum period. Lancet (London, England). 2014;384:1789–99.
The American college of obstetricians and gynecologists committee opinion no. 630. Screening for perinatal depression. Obstet Gynecol. 2015;125:1268–71.
Siu AL, Bibbins-Domingo K, Grossman DC, Baumann LC, Davidson KW, US Preventive Services Task Force (USPSTF), et al. Screening for depression in adults: US preventive services task force recommendation statement. JAMA. 2016;315:380–7.
Article CAS PubMed Google Scholar
Newport DJ, Calamaras MR, DeVane CL, Donovan J, Beach AJ, Winn S, et al. Atypical antipsychotic administration during late pregnancy: Placental passage and obstetrical outcomes. Am J Psychiatry. 2007;164:1214–20.
Corsello G, Giuffrè M. Congenital malformations. J Matern Fetal Neonatal Med. 2012;25(Suppl 1):25–9.
Bellet F, Beyens M-N, Bernard N, Beghin D, Elefant E, Vial T. Exposure to aripiprazole during embryogenesis: a prospective multicenter cohort study. Pharmacoepidem Dr S. 2015;24:368–80.
Vigod SN, Gomes T, Wilton AS, Taylor VH, Ray JG. Antipsychotic drug use in pregnancy: High dimensional, propensity matched, population based cohort study. BMJ (Clinical Research Ed). 2015;350: h2298.
PubMed PubMed Central Google Scholar
Cohen LS, Viguera AC, McInerney KA, Freeman MP, Sosinsky AZ, Moustafa D, et al. Reproductive safety of second-generation antipsychotics: current data from the Massachusetts general hospital national pregnancy registry for atypical antipsychotics. Am J Psychiatry. 2016;173:263–70.
Huybrechts KF, Hernández-Díaz S, Patorno E, Desai RJ, Mogun H, Dejene SZ, et al. Antipsychotic use in pregnancy and the risk for congenital malformations. JAMA Psychiat. 2016;73:938–46.
Petersen I, McCrea RL, Sammon CJ, Osborn DPJ, Evans SJ, Cowen PJ, et al. Risks and benefits of psychotropic medication in pregnancy: Cohort studies based on UK electronic primary care health records. Health Technol Assess (Winchester, England). 2016;20:1–176.
Article PubMed Central Google Scholar
Gentile S, Fusco ML. Schizophrenia and motherhood. Psychiatry Clin Neurosci. 2019;73:376–85.
Damkier P, Videbech P. The safety of second-generation antipsychotics during pregnancy: a clinically focused review. CNS Drugs. 2018;32:351–66.
Article CAS PubMed Google Scholar
Thomson M, Sharma V. Weighing the risks: the management of bipolar disorder during pregnancy. Curr Psychiatry Rep. 2018;20:20.
Kulkarni J, Storch A, Baraniuk A, Gilbert H, Gavrilidis E, Worsley R. Antipsychotic use in pregnancy. Expert Opin Pharmacother. 2015;16:1335–45.
Article CAS PubMed Google Scholar
Cuomo A, Goracci A, Fagiolini A. Aripiprazole use during pregnancy, peripartum and lactation. A systematic literature search and review to inform clinical practice. J Affect Disord. 2018;228:229–37.
Article CAS PubMed Google Scholar
Mehta TM, Van Lieshout RJ. A review of the safety of clozapine during pregnancy and lactation. Arch Women’s Mental Health. 2017;20:1–9.
Ennis ZN, Damkier P. Pregnancy exposure to olanzapine, quetiapine, risperidone, aripiprazole and risk of congenital malformations. A systematic review. Basic Clin Pharmacol Toxicol. 2015;116:315–20.
Article CAS PubMed Google Scholar
Coughlin CG, Blackwell KA, Bartley C, Hay M, Yonkers KA, Bloch MH. Obstetric and neonatal outcomes after antipsychotic medication exposure in pregnancy. Obstet Gynecol. 2015;125:1224–35.
Article CAS PubMed PubMed Central Google Scholar
Wang Z, Brauer R, Man KKC, Alfageh B, Mongkhon P, Wong ICK. Prenatal exposure to antipsychotic agents and the risk of congenital malformations in children: a systematic review and meta-analysis. Br J Clin Pharmacol. 2021;87:4101–23.
Andrade C. Major congenital malformations associated with exposure to second-generation antipsychotic drugs during pregnancy. J Clin Psychiatry. 2021;82:21f14252.
O’Sullivan DL, Byatt N, Dossett EC. Long-acting injectable antipsychotic medications in pregnancy: a review. J Acad Consultation-Liaison Psychiatry. 2022;63:53–60.
Betcher HK, Montiel C, Clark CT. Use of antipsychotic drugs during pregnancy. Curr Treat Options Psychiatry. 2019;6:17–31.
Article PubMed PubMed Central Google Scholar
Coppola D, Russo LJ, Kwarta RF, Varughese R, Schmider J. Evaluating the postmarketing experience of risperidone use during pregnancy: pregnancy and neonatal outcomes. Drug Saf. 2007;30:247–64.
Article CAS PubMed Google Scholar
Ellfolk M, Leinonen MK, Gissler M, Kiuru-Kuhlefelt S, Saastamoinen L, Malm H. Second-generation antipsychotic use during pregnancy and risk of congenital malformations. Eur J Clin Pharmacol. 2021;77:1737–45.
Article CAS PubMed PubMed Central Google Scholar
Freeman MP, Viguera AC, Góez-Mogollón L, Young AV, Caplin PS, McElheny SA, et al. Reproductive safety of aripiprazole: Data from the massachusetts general hospital national pregnancy registry for atypical antipsychotics. Arch Women’s Mental Health. 2021;24:659–67.
Bafeta A, Trinquart L, Seror R, Ravaud P. Reporting of results from network meta-analyses: methodological systematic review. BMJ (Clinical Research Ed). 2014;348: g1741.
PubMed PubMed Central Google Scholar
The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: Checklist and explanations - PubMed [Internet]. [cited 2024 Aug 14]. https://pubmed.ncbi.nlm.nih.gov/26030634/. Accesssed 14 Aug 2024.
Anomalies ES of C. EUROCAT guide 1.3 and reference documents: Instructions for the registration and surveillance of congenital anomalies. 2005;
Wang R, Shi Q, Jia B, Zhang W, Zhang H, Shan Y, et al. Association of preterm singleton birth with fertility treatment in the US. JAMA Netw Open. 2022;5: e2147782.
Article PubMed PubMed Central Google Scholar
Giakoumelou S, Wheelhouse N, Cuschieri K, Entrican G, Howie SEM, Horne AW. The role of infection in miscarriage. Hum Reprod Update. 2016;22:116–33.
Article CAS PubMed Google Scholar
Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions. BMJ (Clin Res ed). 2016;355: i4919.
Sterne JAC, Hernán MA, McAleenan A, Reeves BC, Higgins JPT. Chapter 25: Assessing risk of bias in a non-randomized study [last updated October 2019]. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al., editors. Cochrane Handbook for Systematic Reviews of Interventions version 65 [Internet]. Version 6.5. Cochrane; 2024. www.training.cochrane.org/handbook.
Hespanhol L, Vallio CS, Costa LM, Saragiotto BT. Understanding and interpreting confidence and credible intervals around effect estimates. Braz J Phys Ther. 2019;23:290–301.
Valkenhoef G van. gemtc: network meta-analysis using Bayesian methods. [Internet]. 2024 [cited 2024 Aug 14]. https://github.com/gertvv/gemtc.
Shim SR, Kim S-J, Lee J, Rücker G. Network meta-analysis: application and practice using R software. Epidemiol Health. 2019;41: e2019013.
Article PubMed PubMed Central Google Scholar
Balduzzi S, Rücker G, Nikolakopoulou A, Papakonstantinou T, Salanti G, Efthimiou O, et al. netmeta: an R package for network meta-analysis using frequentist methods. J Stat Softw. 2023;106:1–40.
StataCorp L. Stata statistical software (version release 14). College Station, TX: Author. 2015;464:14
White IR. Network meta-analysis. [cited 2024 Aug 14]; Available from: https://doi.org/10.1177/1536867X1501500403
留言 (0)